These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2902375)

  • 1. Urokinase versus tissue plasminogen activator in pulmonary embolism.
    Goldhaber SZ; Loscalzo J
    Lancet; 1988 Oct; 2(8616):915. PubMed ID: 2902375
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.
    Goldhaber SZ; Kessler CM; Heit JA; Elliott CG; Friedenberg WR; Heiselman DE; Wilson DB; Parker JA; Bennett D; Feldstein ML
    J Am Coll Cardiol; 1992 Jul; 20(1):24-30. PubMed ID: 1607532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-threatening pulmonary embolism with right-sided heart thrombus. Rapid recovery with recombinant tissue plasminogen activator.
    d'Ivernois C; Le Metayer P; Fischer B; Haissaguerre M; Warin JF
    Chest; 1994 Apr; 105(4):1291-2. PubMed ID: 8162778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue plasminogen activator versus urokinase.
    Ebers GC
    Lancet; 1988 Oct; 2(8618):1028. PubMed ID: 2902476
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombolysis for pulmonary embolism.
    Böttiger BW; Böhrer H
    Lancet; 1992 Oct; 340(8823):852. PubMed ID: 1357272
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?
    Dalen JE; Alpert JS; Hirsh J
    Arch Intern Med; 1997 Dec 8-22; 157(22):2550-6. PubMed ID: 9531222
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue plasminogen activator in acute pulmonary embolism.
    Goldhaber SZ
    Chest; 1989 May; 95(5 Suppl):282S-289S. PubMed ID: 2495913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism.
    Goldhaber SZ; Kessler CM; Heit J; Markis J; Sharma GV; Dawley D; Nagel JS; Meyerovitz M; Kim D; Vaughan DE
    Lancet; 1988 Aug; 2(8606):293-8. PubMed ID: 2899718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute pulmonary embolism].
    Meissner E; Niedermeyer J; Fabel H
    Z Kardiol; 1993; 82 Suppl 2():3-12. PubMed ID: 8328207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolysis for pulmonary embolism.
    Lancet; 1992 Jul; 340(8810):21-2. PubMed ID: 1351604
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolytic therapy in canine pulmonary embolism. Comparative effects of urokinase and recombinant tissue plasminogen activator.
    Prewitt RM; Hoy C; Kong A; Gu SA; Greenberg D; Cook R; Chan SM; Ducas J
    Am Rev Respir Dis; 1990 Feb; 141(2):290-5. PubMed ID: 2105682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic treatment of pulmonary embolism.
    Palevsky HI; Raffin TA
    West J Med; 1992 Aug; 157(2):171. PubMed ID: 1441471
    [No Abstract]   [Full Text] [Related]  

  • 13. When urokinase was gone: commentary on another year of thrombolysis without urokinase.
    Gates J; Hartnell GG
    J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 1):1-5. PubMed ID: 14709680
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary embolism thrombolysis: a clarion call for international collaboration.
    Goldhaber SZ
    J Am Coll Cardiol; 1992 Feb; 19(2):246-7. PubMed ID: 1732348
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid reversal of canine thromboembolic pulmonary hypertension by bolus injection of the novel recombinant plasminogen activator BM 06.022.
    Martin U; Sponer G; Strein K
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):455-61. PubMed ID: 7681508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic effects of tissue-type and urokinase-type plasminogen activators in rabbits with experimental pulmonary thromboembolization.
    Rahman F
    Fukuoka Igaku Zasshi; 1990 Sep; 81(9):303-12. PubMed ID: 2125971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired resolution of massive pulmonary embolism associated with an inhibited fibrinolytic response.
    Deitcher SR; Lucore CL; Eisenberg PR
    Am J Med; 1994 May; 96(5):483-4. PubMed ID: 8192182
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolytic therapy of acute pulmonary embolism: current status and future potential.
    Goldhaber SZ; Meyerovitz MF; Markis JE; Kim D; Kessler CM; Sharma GV; Vaughan DE; Selwyn AP; Dawley DL; Loscalzo J
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):96B-104B. PubMed ID: 3117862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism.
    Meyer G; Sors H; Charbonnier B; Kasper W; Bassand JP; Kerr IH; Lesaffre E; Vanhove P; Verstraete M
    J Am Coll Cardiol; 1992 Feb; 19(2):239-45. PubMed ID: 1732347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress on thrombolytic treatment].
    Kazama M
    Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):885-90. PubMed ID: 1919203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.